Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Primitive Myxoid Mesenchymal Tumor of Infancy: A Clinicopathologic Report of 6 Cases

Alaggio, Rita MD*; Ninfo, Vito MD*; Rosolen, Angelo MD; Coffin, Cheryl M. MD

The American Journal of Surgical Pathology: March 2006 - Volume 30 - Issue 3 - p 388-394
doi: 10.1097/01.pas.0000190784.18198.d8
Original Articles

Soft tissue sarcomas in the first year of life are rare, and the most common sarcomas in infancy are embryonal rhabdomyosarcoma, Ewing sarcoma/primitive neuroectodermal tumor, congenital infantile fibrosarcoma, and primitive sarcomas such as undifferentiated sarcoma. In this study, we report 6 cases of a primitive myxoid mesenchymal tumor of infancy (PMMTI), which previously may have been included under the diagnostic categories of congenital-infantile fibrosarcoma or infantile fibromatosis. PMMTI occurred in 6 infants, 3 of whom had a congenital presentation of a soft tissue mass. All patients were otherwise healthy. The tumors occurred on the trunk, extremities, and head and neck. Grossly, the tumors were nonencapsulated and had a multinodular appearance with focal infiltrative growth, a white fleshy cut surface, and a tumor diameter ranging from 2 to 15 cm. Histologically, a diffuse growth of primitive spindle, polygonal, and round cells occurred in a myxoid background. The tumor cells were arranged in a vaguely nodular pattern with peripheral collagenized stroma, higher cellularity at the periphery, and a delicate vascular network in the background. Immunohistochemically, the tumors displayed diffuse reactivity for vimentin and no reactivity for smooth muscle actin, muscle specific actin, desmin, S-100 protein, or myogenin. Electron microscopy documented a poorly differentiated fibroblastic proliferation. Four cases tested negative for the ETV6-NTRK3 gene fusion by RT-PCR. One tumor had a complex karyotypic abnormality with rearrangements involving chromosomes Y, 9, and 3. Three patients had recurrences or metastasis treated with a combination of surgery and chemotherapy. One patient is alive with persistent locally aggressive disease, 2 are alive with no evidence of recurrence, 1 had a recurrence treated surgically without further follow-up information, 1 patient died with persistent tumor and sepsis 6 weeks after diagnosis, and 1 patient was lost to follow-up. The morphologic appearance combined with the ultrastructural features and absence of the typical gene rearrangement of congenital-infantile fibrosarcoma are unique, and we propose that PMMTI represents a new category of pediatric fibroblastic-myofibroblastic tumor.

*Department of Oncology and Surgery, Section of Pathology

Department of Pediatrics, University of Padova, Padova, Italy

Department of Pathology, Primary Children's Medical Center and University of Utah School of Medicine, Salt Lake City, UT

Supported in part by a grant from the Berlucchi Cancer Foundation, Padova, Italy.

Reprints: Cheryl M. Coffin, MD, Department of Pathology, Primary Children's Medical Center, 100 North Medical Drive, Salt Lake City, UT 84113 (e-mail:

© 2006 Lippincott Williams & Wilkins, Inc.